Free Trial
OTCMKTS:RHHBY

Roche (RHHBY) Stock Price, News & Analysis

Roche logo
$37.65 -2.37 (-5.92%)
As of 03:59 PM Eastern

About Roche Stock (OTCMKTS:RHHBY)

Key Stats

Today's Range
$37.44
$39.66
50-Day Range
$38.05
$44.24
52-Week Range
$29.20
$44.31
Volume
3.87 million shs
Average Volume
3.24 million shs
Market Capitalization
$240.13 billion
P/E Ratio
N/A
Dividend Yield
2.26%
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Remove Ads
Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Stock News Headlines

Roche’s Genentech present data on trontinemab, Elecsys plasma test
EMA put clinical hold on Roche, Sarepta DMD studies after death
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
See More Headlines

RHHBY Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $34.88 at the beginning of the year. Since then, RHHBY stock has increased by 7.9% and is now trading at $37.65.
View the best growth stocks for 2025 here
.

Roche subsidiaries include these companies: Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and more.

Top institutional shareholders of Roche include Boston Common Asset Management LLC (0.01%) and Confluence Investment Management LLC.

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
103,605
Year Founded
1896

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
13.40
P/E Growth
2.18
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.73 billion
Cash Flow
$2.94 per share
Price / Cash Flow
12.82
Book Value
$5.81 per share
Price / Book
6.48

Miscellaneous

Outstanding Shares
6,377,936,000
Free Float
N/A
Market Cap
$240.13 billion
Optionable
Not Optionable
Beta
0.48

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:RHHBY) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners